My Watchlist for Monday, August 15
( click to enlarge )
Tobira Therapeutics Inc (NASDAQ:TBRA) broke out of a bottom/accumulation pattern. Friday's volume was the highest in the past one month and the rally was helped by the strong accumulation of traders on the buyside (strong participation). Over the last four trading sessions, TBRA has witnessed green candles on increasing volume. So, I hope that everyone has had an opportunity to take a look at the stock since it is on the uptick. With the RSI rising off an extreme oversold position and with MACD crossing over the signal line, the stock looks prime for a strong bounce. Technical indicators point to TBRA being in an upward trend already but this could be just the beginning of a breakout that could bring good returns. Plus, two analysts have reiterated/raised their price targets (Cowen $11 and H.C. $31) on TBRA in the past week. If momentum continues we could see a Major Potential Bounce that could possibly send the stock to +$6.
( click to enlarge )
Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) price action is coiling up slightly below the 50MA in anticipation of a breakout with directional conviction. Only a close above 3.46 would suggest further upside. Accumulation line is pointing up, which means it is under accumulation. The MACD is also moving higher. DRNA will move quickly, so keep a very close eye on the stock.
( click to enlarge )
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) The major resistance has been broken in this daily technical chart. The price can move up to $5.62-$5.75 in the short-term. The stock has been doing well recently as +DI line is on top of -DI line with MACD on top of signal line. Now that the stock is above this horizontal resistance line more buyers should be coming. The stock hit a high of 5.48, which is resistance for Monday’s move.
( click to enlarge )
Shares of BlackBerry Ltd (NASDAQ:BBRY) got a nice boost Friday following an upgrade from Raymond James, closing the session with gains of over 2.5%. Analyst Steven Li raised his rating on the stock to outperform and hiked his price target to $10.5. From a technica perspective, the stock has made a strong bounce off of the lows that were posted in June with high volume and looks poised to clear this major resistance area. If a proper breakout happens at $8.36 we can see a target of $9.46
( click to enlarge )
Himax Technologies, Inc. (NASDAQ:HIMX) broke the downtrend line that it established since April and traded nearly 3x normal daily volume. The close near its high on Friday, should bode well for the stock in the coming week. From a technical standpoint, the stock is now trading above all the major short-term EMAs and the MACD triggered a new buy signal, indicating that a new upward cycle has begun. Let's keep an eye on it.
( click to enlarge )
We finally got the breakout in Seres Therapeutics Inc (NASDAQ:MCRB). Shares rallied past resistance of $10.08 and hit my trigger to open positions. I will be watching the stock on Monday, looking for a follow-through move.
( click to enlarge )
SCYNEXIS Inc (NASDAQ:SCYX) has been trying to bottom for a couple of days now. There have been some pretty bullish candles forming on daily and it seems to me like it is ready to turn up. Honestly, i believe the stock may attempt to go higher from here. If the near-by support at $2.10 (EMA9 & 13) holds up next week, a rally up to the $2.35 level is probable or even possible. Recent insider activity has been very BULLISH, which means the executives are optimistic about the company and the stock is really worth buying. The daily technical chart above continue to show a bullish bias. The MACD line is pointing up. RSI is also increasing and the +DI is starting to get ready to cross -DI. Immediate resistance is $2.22. If the stock can break through this area, we should see a strong upside move. Watch SCYX closely on Monday.
( click to enlarge )
AveXis Inc (NASDAQ:AVXS) was a big winner Friday, as the stock closed up $5.7 on heavy volume. I feel that there will be a continuation move next week, but i want to see a close above 41.50 before I buy. There are several short term technical indications suggesting that AVXS could make a move to higher levels. Worth putting on the watchlist.
This weekend and as usual in the past weeks, I would like to talk about the new feature introduced by Stockal in the app, it’s called Confidence Meter. Basically this new parameter aggregated analyst opinion for any stock. Stockal takes inputs from about 200 Wall St analyst firms, then on the basis of individual firm reputations and past performance history, they create unique analyst profiles that are taken into consideration while coming out with a unified Confidence Meter. It’s an interesting little parameter because it converts tons of textual opinions and ratings (upgrades/downgrades) into solid numbers that can be analysed, charted out, compared etc! Stockal seems to be giving pretty good results for its new parameter, Benzinga recently wrote about it too. To get Confidence Meter and other modern investing signals for your stocks, you should take a look at the Stockal app - (iPhone) and (Android). By the way, you can also trade in the app via your favorite brokers and chat with other investors, experts and friends. Do give it a spin !!
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
This weekend and as usual in the past weeks, I would like to talk about the new feature introduced by Stockal in the app, it’s called Confidence Meter. Basically this new parameter aggregated analyst opinion for any stock. Stockal takes inputs from about 200 Wall St analyst firms, then on the basis of individual firm reputations and past performance history, they create unique analyst profiles that are taken into consideration while coming out with a unified Confidence Meter. It’s an interesting little parameter because it converts tons of textual opinions and ratings (upgrades/downgrades) into solid numbers that can be analysed, charted out, compared etc! Stockal seems to be giving pretty good results for its new parameter, Benzinga recently wrote about it too. To get Confidence Meter and other modern investing signals for your stocks, you should take a look at the Stockal app - (iPhone) and (Android). By the way, you can also trade in the app via your favorite brokers and chat with other investors, experts and friends. Do give it a spin !!
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: AVXS, BBRY, DRNA, HIMX, MCRB, SCYX, TBRA, ZIOP
| Permalink | 
